000 01581 a2200457 4500
005 20250517193910.0
264 0 _c20181015
008 201810s 0 0 eng d
022 _a1756-185X
024 7 _a10.1111/1756-185X.13251
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTootsi, Kaspar
245 0 0 _aMedium- and long-chain acylcarnitines are associated with osteoarthritis severity and arterial stiffness in end-stage osteoarthritis patients: a case-control study.
_h[electronic resource]
260 _bInternational journal of rheumatic diseases
_cJun 2018
300 _a1211-1218 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aBiomarkers
_xblood
650 0 4 _aCarnitine
_xanalogs & derivatives
650 0 4 _aCase-Control Studies
650 0 4 _aDown-Regulation
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMetabolomics
_xmethods
650 0 4 _aMiddle Aged
650 0 4 _aOsteoarthritis, Hip
_xblood
650 0 4 _aOsteoarthritis, Knee
_xblood
650 0 4 _aPrincipal Component Analysis
650 0 4 _aProspective Studies
650 0 4 _aPulse Wave Analysis
650 0 4 _aSeverity of Illness Index
650 0 4 _aVascular Stiffness
700 1 _aKals, Jaak
700 1 _aZilmer, Mihkel
700 1 _aPaapstel, Kaido
700 1 _aOttas, Aigar
700 1 _aMärtson, Aare
773 0 _tInternational journal of rheumatic diseases
_gvol. 21
_gno. 6
_gp. 1211-1218
856 4 0 _uhttps://doi.org/10.1111/1756-185X.13251
_zAvailable from publisher's website
999 _c27961385
_d27961385